About Praxis Precision Medicines Inc. Praxis Precision Medicines, Inc. is a clinical-stage genetic neuroscience company that develops therapies for patients and families affected by complex and ...
About Praxis Precision Medicines Inc. Praxis Precision Medicines, Inc. is a clinical-stage genetic neuroscience company that develops therapies for patients and families affected by complex and ...
Affinity Asset Advisors initiated a new position in PRAX, adding 185,000 shares for an estimated $54.53 million in the fourth quarter. The transaction resulted in the PRAX position representing 3.11% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results